Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ghiath M. Sukhtian

Director at Outlook Therapeutics, Inc. (OTLK)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys−$987K
Total bought / sold$2.5M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 14SEC OTLKOutlook Therapeutics, Inc. Buy 2,525,25224,617,320 held (+11%) $0.99 $2.5M -39.5%
  • Buy

    Director Ghiath M. Sukhtian bought $2.5M of OTLK at $0.99 — first open-market purchase in our records.